Pharmaceutical compositions and methods of inhibiting phenylethanolamine
申请人:SmithKline Corporation
公开号:US03988339A1
公开(公告)日:1976-10-26
Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using 7 and/or 8 substituted 1,2,3,4-tetrahydroisoquinoline compounds.
制药组合物和使用7和/或8取代的1,2,3,4-四氢异喹啉化合物抑制苯乙醇胺N-甲基转移酶的方法。
Method of producing alpha.sub.2 antagonism
申请人:Smithkline Corporation
公开号:US04352809A1
公开(公告)日:1982-10-05
Method of producing alpha.sub.2 antagonism by administering thiadiazolo- and oxadiazolotetrahydroisoquinoline compounds.
通过给予噻二唑和氧二唑四氢异喹啉化合物的方法产生α.sub.2拮抗作用。
Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and
申请人:SmithKline Corporation
公开号:US04258049A1
公开(公告)日:1981-03-24
Thiadiazolo- and oxadiazolotetrahydroisoquinoline compounds are inhibitors of phenylethanolamine N-methyltransferase.
Hepatitis C virus inhibitors are disclosed having the general formula:
wherein R
1
, R
2
, R
3
, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Tetrahydroisoquinoline derivatives, process for preparing them and compositions containing them
申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0023761A1
公开(公告)日:1981-02-11
Thiadiazolo- and oxadiazolo-tetrahydroisoquinoline derivatives which are inhibitors of phenylethanolamine N-methyltransferase which catalyzes the final step in the biosynthesis of epinephrine. The compounds of the invention can be prepared by various methods, and in general they will be administered as pharmaceutical compositions.